1 reports of this reaction
3.2% of all 5% LIDOCAINE reports
#5 most reported adverse reaction
CONVULSION is the #5 most commonly reported adverse reaction for 5% LIDOCAINE, manufactured by 100 KARMA INC. There are 1 FDA adverse event reports linking 5% LIDOCAINE to CONVULSION. This represents approximately 3.2% of all 31 adverse event reports for this drug.
Patients taking 5% LIDOCAINE who experience convulsion should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONVULSION is moderately reported among 5% LIDOCAINE users, representing a notable but not dominant share of adverse events.
In addition to convulsion, the following adverse reactions have been reported for 5% LIDOCAINE:
The following drugs have also been linked to convulsion in FDA adverse event reports:
CONVULSION has been reported as an adverse event in 1 FDA reports for 5% LIDOCAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONVULSION accounts for approximately 3.2% of all adverse event reports for 5% LIDOCAINE, making it a notable side effect.
If you experience convulsion while taking 5% LIDOCAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.